Live Breaking News & Updates on Senthil selvaraj

Stay informed with the latest breaking news from Senthil selvaraj on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Senthil selvaraj and stay connected to the pulse of your community

Center for Precision Health Welcomes New Faculty Leaders

Center for Precision Health Welcomes New Faculty Leaders
duke.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from duke.edu Daily Mail and Mail on Sunday newspapers.

Lori-orlando , Kwok-ian-wong , Mihaiv-podgoreanu , Nina-sperber , Deepak-voora , Susanne-haga , Micah-mcclain , Senthil-selvaraj , Svatih-shah , Eun-sil-shelley-hwang , Department-of-surgery , Va-national-pharmacogenomics-program

The Foundation for Sarcoidosis Research (FSR) awards

The Foundation for Sarcoidosis Research (FSR) awards $100,000 in support of cardiac sarcoidosis....

Chicago , Illinois , United-states , Ashley-kiemen , Cathi-davis , Paco-bravo , Nisha-gilotra , Senthil-selvaraj , Mary-mcgowan , Abdel-daoud , Johns-hopkins-university , Foundation-for-sarcoidosis-research

The Foundation for Sarcoidosis Research (FSR) awards $100,000 in support of cardiac sarcoidosis

CHICAGO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Foundation for Sarcoidosis Research (FSR) announces $100,000 in funding for support of research aimed at improving…

Chicago , Illinois , United-states , Senthil-selvaraj , Foundation-for-sarcoidosis-research , Sarcoidosis-research , Assistant-professor , Advanced-heart , News , Ggregator , Reaking-news , Uration

Dapagliflozin DELIVERs Regardless of BP in Preserved-EF HF

The finding may alleviate long-standing concerns that starting modestly diuretic SGLT2 inhibitors in patients with HF might present a hazard to those with a low systolic BP, researchers say.

Maryland , United-states , National-harbor , North-carolina , Duke-university , America , Coll-cardiol , Senthil-selvaraj , Heart-failure-society-of-america , Amgen , Duke-university-school-of-medicine , University-of-california-los-angeles-medical-center

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

May 16, 2021
Compared with valsartan alone, the angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril/valsartan (Entresto; Novartis) reduces triglycerides among patients with heart failure and preserved ejection fraction (HFpEF), according to results from a PARAGON-HF subanalysis. The effect was particularly marked in patients with higher triglycerides at baseline.
“Our research adds to the growing literature of the favorable metabolic effects of sacubitril/valsartan,” Senthil Selvaraj, MD (Hospital of the University of Pennsylvania, Philadelphia), who presented the findings today at the American College of Cardiology 2021 Scientific Session, told TCTMD in an email. “Sacubitril/valsartan may be part of the therapeutic armamentarium is reducing triglycerides as adjunct therapy. However, outcomes studies looking at related cardiovascular endpoints in high-risk populations are needed.”

United-states , Philadelphia , Pennsylvania , American , J-emanuel-finet , Senthil-selvaraj , American-college-of-cardiology , Journal-of-the-american-heart-association , Drug-administration , Md-hospital-of-the-university-pennsylvania , Novartis , American-college

PARAGON-HF: Sacubitril/valsartan reduces triglyceride levels in HFpEF

PARAGON-HF: Sacubitril/valsartan reduces triglyceride levels in HFpEF
Source:
Selvaraj S, et al. Public Health and Heart Failure: Emerging Evidence. Presented at: American College of Cardiology Scientific Session; May 15-17, 2021 (virtual meeting).
Disclosures:
Selvaraj reports no relevant financial disclosures. Please see the study for the other authors’ relevant financial disclosures.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Subscribe
ADDED TO EMAIL ALERTS
You've successfully added to your alerts. You will receive an email when new content is published.

United-states , American , Anthony-vecchione , Senthil-selvaraj , Public-health , American-college-of-cardiology-scientific-session , Journal-of-the-american-heart-association , Novartis , Heart-failure , American-college , Cardiology-scientific-session , Cardiology-scientific